Susquehanna International Group
SGRY icon

Susquehanna International Group’s Surgery Partners SGRY Stock Holding History

Susquehanna International Group’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,200
Closed -$312K – 14417
2026
Q1 		$312K Sell
26,200
-78,000
-75% -$1.12M ﹤0.01% 10774
2025
Q4 		$1.61M Sell
104,200
-306,400
-75% -$5.63M ﹤0.01% 6092
2025
Q3 		$8.89M Sell
410,600
-24,900
-6% -$555K ﹤0.01% 3187
2025
Q2 		$9.68M Buy
435,500
+397,500
+1,046% +$8.84M ﹤0.01% 2880
2025
Q1 		$903K Buy
+38,000
New +$899K ﹤0.01% 7504
2024
Q4 		– Sell
-26,000
Closed -$838K – 13113
2024
Q3 		$838K Buy
26,000
+15,900
+157% +$470K ﹤0.01% 7227
2024
Q2 		$240K Sell
10,100
-57,800
-85% -$1.48M ﹤0.01% 9953
2024
Q1 		$2.03M Buy
67,900
+3,200
+5% +$100K ﹤0.01% 5313
2023
Q4 		$2.07M Sell
64,700
-15,300
-19% -$444K ﹤0.01% 5262
2023
Q3 		$2.34M Buy
80,000
+41,400
+107% +$1.49M ﹤0.01% 4837
2023
Q2 		$1.74M Buy
38,600
+17,000
+79% +$649K ﹤0.01% 5440
2023
Q1 		$745K Buy
+21,600
New +$701K ﹤0.01% 7574
2022
Q3 		– Sell
-8,400
Closed -$243K – 14026
2022
Q2 		$243K Buy
+8,400
New +$367K ﹤0.01% 10140
2022
Q1 		– Sell
-19,500
Closed -$1.04M – 13874
2021
Q4 		$1.04M Sell
19,500
-9,800
-33% -$455K ﹤0.01% 7186
2021
Q3 		$1.24M Buy
29,300
+200
+0.7% +$10.2K ﹤0.01% 6992
2021
Q2 		$1.94M Buy
29,100
+3,700
+15% +$201K ﹤0.01% 5987
2021
Q1 		$1.12M Buy
25,400
+15,400
+154% +$572K ﹤0.01% 7432
2020
Q4 		$290K Sell
10,000
-5,000
-33% -$124K ﹤0.01% 9332
2020
Q3 		$329K Buy
15,000
+4,700
+46% +$83.5K ﹤0.01% 8518
2020
Q2 		$119K Buy
+10,300
New +$113K ﹤0.01% 9408
2018
Q4 		– Sell
-20,000
Closed -$330K – 9863
2018
Q3 		$330K Buy
+20,000
New +$319K ﹤0.01% 7307
2018
Q1 		– Sell
-10,900
Closed -$132K – 10082
2017
Q4 		$132K Sell
10,900
-6,300
-37% -$60.2K ﹤0.01% 8574
2017
Q3 		$178K Buy
17,200
+2,800
+19% +$40K ﹤0.01% 8102
2017
Q2 		$328K Sell
14,400
-400
-3% -$8.22K ﹤0.01% 7419
2017
Q1 		$289K Buy
+14,800
New +$288K ﹤0.01% 7400

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KSCM
King Street Capital Management New York $190M AUM 16.01% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Susquehanna International Group's SGRY Position: Q2 2026 in Review

Susquehanna International Group increased its Surgery Partners (SGRY) stake by 131% in Q2 2026, buying an estimated $870K and bringing the position to 109,264 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #6684.

Susquehanna International Group first reported a position in SGRY in Q4 2015 and has held it in 29 quarters since. The position peaked at $22.7M in Q2 2023. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Susquehanna International Group held 109,264 shares of Surgery Partners worth $1.84M as of Q2 2026.
  • Susquehanna International Group bought 61,960 Surgery Partners shares in Q2 2026, an estimated $870K.
  • Surgery Partners made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #6684 holding.
  • Susquehanna International Group first reported a position in Surgery Partners in Q4 2015 and has held it in 29 quarters since.
  • Susquehanna International Group's Surgery Partners position peaked at $22.7M in Q2 2023.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.